News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ilypsa, Inc. Raises $36 Million For Kidney Drugs


10/19/2005 5:11:57 PM

July 20, 2005 -- Ilypsa Inc. has raised $36 million in a series B round, which the company said would provide enough cash for the next two years of operations. By that time, the company hopes to have completed Phase II tests of its two treatments for advanced renal disease. The company develops non-absorbed polymers which, sitting in the gut, absorb excess potassium, phosphate, and other electrolytes or metabolites that would normally be cleared by the kidney. We look at the drug candidates from the company and its history...

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES